Last €17.80 EUR
Change Today -0.275 / -1.52%
Volume 12.7K
As of 3:35 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

mevis medical solutions ag (M3V) Snapshot

Open
€18.02
Previous Close
€18.07
Day High
€18.54
Day Low
€17.80
52 Week High
01/9/14 - €23.45
52 Week Low
10/16/14 - €12.38
Market Cap
32.4M
Average Volume 10 Days
8.5K
EPS TTM
€2.43
Shares Outstanding
1.8M
EX-Date
--
P/E TM
7.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for MEVIS MEDICAL SOLUTIONS AG (M3V)

Related News

No related news articles were found.

mevis medical solutions ag (M3V) Related Businessweek News

No Related Businessweek News Found

mevis medical solutions ag (M3V) Details

MeVis Medical Solutions AG, together with its subsidiaries, develops, markets, and sells software for analyzing and evaluating image data to equipment manufacturers of medical devices and providers of medical IT platforms. Its clinical focuses include image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, prostate, and colon cancers, as well as neurological disorders. It operates in two segments, Digital Mammography and Other Diagnostics. The Digital Mammography segment develops and markets software products, which support breast diagnostic imaging and intervention. This segment also offers software applications for imaging techniques and digital mammography, such as ultrasound, magnetic resonance imaging, and tomosynthesis. The Other Diagnostics segment provides digital radiology products, including magnetic resonance imaging and computer tomography for diseases, such as lung, prostate, and intestinal disorders, as well as general image-based analysis and diagnostics of radiology images. This segment also offers image and risk analysis for planning liver surgery and tumor diagnostics in connection with clinical studies of pharmaceutical companies. The company has operations in the United States, Europe, and internationally. MeVis Medical Solutions AG was founded in 1992 and is based in Bremen, Germany.

93 Employees
Last Reported Date: 11/17/14
Founded in 1992

mevis medical solutions ag (M3V) Top Compensated Officers

Chairman of the Executive Board and Chief Exe...
Total Annual Compensation: €306.3K
Chief Financial Officer and Member of Executi...
Total Annual Compensation: €243.4K
Compensation as of Fiscal Year 2013.

mevis medical solutions ag (M3V) Key Developments

MeVis Medical Solutions AG Revises Earnings Guidance for the Fiscal Year of 2014

MeVis Medical Solutions AG revises earnings guidance for the fiscal year of 2014. For the year 2014, the company revenues are expected to remain stable at between EUR 12.5 and EUR 13.0 million compared to previous forecast to slight decline in revenues to between EUR 12.0 and 12.5 million. For the EBIT (earnings before interest and taxes), a slight decrease over the previous year continues to be expected, at EUR 3.5 to EUR 4.0 million compared to previous forecast of EBIT between EUR 3.0 and 3.5 million. For the end of 2014 another increase in liquidity is expected to now EUR 16.5 to EUR 17.5 million due to a continued positive cash flow compared to previous forecast of EUR 15.0 to EUR 16.0 million. The company raises its forecast for the present fiscal year due to the current business development.

MeVis Medical Solutions AG Presents at 4th Annual Berenberg 1 - 1 Symposium @ German Equity Forum, Nov-25-2014

MeVis Medical Solutions AG Presents at 4th Annual Berenberg 1 - 1 Symposium @ German Equity Forum, Nov-25-2014 . Venue: Maritim Hotel, Theodor-Heuss-Allee 3, 60486 Frankfurt am Main, Germany.

MeVis Medical Solutions AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Provides Earnings Guidance for the Year 2014

MeVis Medical Solutions AG reported earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company’s sales amounted to EUR 3,599,000, slightly above the previous year's level of EUR 3,554,000 and well in excess of the first two quarters of 2014. For the nine months, the company’s sales were just slightly lower year on year at EUR 9,661,000 compared to EUR 9,712,000 a year ago. EBIT was EUR 3,150,000, down a sharp 10 % on the previous year's figure of EUR 3,485,000. After-tax earnings increased by EUR 507,000 to EUR 3,456,000, which is equivalent to earnings per share of EUR 2.01 compared to previous year of EUR 1.71. Profit for the period up sharply to EUR 3.5 million compared to EUR 2.9 million a year ago. For the year 2014, the company anticipates EBIT to fall slightly to between EUR 3.0 million and EUR 3.5 million.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
M3V:GR €17.80 EUR -0.275

M3V Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for M3V.
View Industry Companies
 

Industry Analysis

M3V

Industry Average

Valuation M3V Industry Range
Price/Earnings 7.1x
Price/Sales 1.9x
Price/Book 1.0x
Price/Cash Flow 5.0x
TEV/Sales 1.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEVIS MEDICAL SOLUTIONS AG, please visit www.mevis.de. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.